Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.43M Sell
19,678
-128,445
-87% -$23.6M 2.26% 3
2025
Q4
$3.26M Buy
148,123
+130,652
+748% +$24.3M 2.27% 4
2025
Q3
$3.26M Buy
17,471
+38
+0.2% +$6.62K 2.58% 4
2025
Q2
$2.75M Buy
17,433
+212
+1% +$26.7K 2.24% 4
2025
Q1
$1.87M Buy
17,221
+4,120
+31% +$522K 1.48% 7
2024
Q4
$1.75M Buy
13,101
+7,584
+137% +$1.05M 2.14% 4
2024
Q3
$677K Buy
5,517
+3,599
+188% +$425K 0.67% 46
2024
Q2
$448K Sell
1,918
-3,962
-67% -$401K 0.47% 68
2024
Q1
$531K Buy
5,880
+980
+20% +$71K 0.57% 54
2023
Q4
$243K Buy
+4,900
New +$227K 0.3% 97

Other funds holding NVDA

FSA Advisors's NVDA Position: Q1 2026 in Review

FSA Advisors reduced its NVIDIA (NVDA) stake by 87% in Q1 2026, selling an estimated $23.6M and leaving 19,678 shares worth $3.43M. The position accounts for 2.26% of the portfolio, ranked #3.

FSA Advisors first reported a position in NVDA in Q4 2023 and has held it in 10 quarters since. 5,826 funds tracked by Wall St. Rank hold NVDA as of Q1 2026.

  • FSA Advisors held 19,678 shares of NVIDIA worth $3.43M as of Q1 2026.
  • FSA Advisors sold 128,445 NVIDIA shares in Q1 2026, an estimated $23.6M.
  • NVIDIA made up 2.26% of FSA Advisors's portfolio in Q1 2026, its #3 holding.
  • FSA Advisors first reported a position in NVIDIA in Q4 2023 and has held it in 10 quarters since.
  • 5,826 funds tracked by Wall St. Rank held NVIDIA as of Q1 2026.

Based on FSA Advisors's 13F filing for Q1 2026, filed 6 May 2026.